register

News & Trends - Pharmaceuticals

New discovery promising for millions at risk from antibiotic resistance

Health Industry Hub | August 18, 2020 |

Pharma News: There is new hope for approximately 700,000 people who die each year from antibiotic resistant infections, with University of Queensland researchers discovering how bacteria share antibiotic-resistance genes.

UQ’s Professor Mark Schembri said antibiotic resistant bacteria, in particular emerging ‘superbugs’, could lead to around 10 million deaths globally by 2050.

“The diminishing pool of effective antibiotics makes these infections a major threat to human health, so it’s critical we understand the exact mechanics of how antibiotic resistance spreads between different bacteria,” Professor Schembri said.

“In this study, we examined plasmids – self-replicating DNA molecules – which are one of the major drivers for the rapid spread of antibiotic resistance genes between bacteria.

“Many plasmids carry 10 to 15 antibiotic resistance-causing genes, and when they transfer from one bacterial cell to another, two important things happen.

“Firstly, the plasmid is copied so that it is retained by both the donor and recipient cell, and secondly all antibiotic resistance genes are transferred together, meaning that resistance to multiple antibiotics can be transferred and acquired simultaneously.”

Lead author Dr Steven Hancock said the study used a powerful genetic screening system to identify all of the components required for the transfer of an important type of antibiotic resistance plasmid from one bacterial cell to another.

“Our investigation discovered genes encoding the ‘syringe’ component,” Dr Hancock said.

“That is the mechanism through which plasmid DNA is mobilised, as well as a novel controlling element essential for regulation of the transfer process.”

The team also investigated the crystal structure of this controlling element, and revealed how it binds to DNA and activates transcription of other genes involved in the transfer.

Professor Schembri said this deeper understanding would open the door to solutions for this ever-growing health crisis.

“Preventing the transfer of plasmids between bacteria has been a major challenge in reducing the spread of antibiotic resistance genes,” he said.

“By looking at the molecular mechanics, we can start to develop effective solutions for stopping these genes in their tracks.

“Almost everyone has suffered an infection that did not respond to a first round of antibiotic treatment, only to be fortunate enough to be treated with a different antibiotic that worked.

“Now, in extreme cases, we’re seeing common infections caused by superbugs that are resistant to all available antibiotics, highlighting the increasing challenge of antibiotic resistance.

“We need to tackle this now, and I’m excited to see how this new knowledge will lead to novel approaches, potentially saving millions of lives globally.”


Human Resources

Medtronic HR Director deep dives into shifting workplaces and leadership trends: International HR Day

Medtronic HR Director deep dives into shifting workplaces and leadership trends: International HR Day

Health Industry Hub | May 20, 2024 |

People & Culture: Coinciding with International HR Day, Karen Newell, Senior HR Director for ANZ at Medtronic, joined Health Industry […]

More


News & Trends - MedTech & Diagnostics

Aussie medtech reveals new data on next-gen pulsed field ablation system for atrial fibrillation

Aussie medtech reveals new data on next-gen pulsed field ablation system for atrial fibrillation

Health Industry Hub | May 20, 2024 |

MedTech & Diagnostics News: An Australian-based medtech company announced promising results from the first-in-human study for its pulsed field ablation […]

More


News & Trends - MedTech & Diagnostics

Federal budget delivers 'mixed news' for radiologists

Federal budget delivers ‘mixed news’ for radiologists

Health Industry Hub | May 20, 2024 |

MedTech & Diagnostics News: The Royal College of Australian and New Zealand Radiologists (RANZCR) and the Interventional Radiology Society of […]

More


News & Trends - Pharmaceuticals

AstraZeneca, BMS and Noxopharm address findings of inquiry report into rare cancers

AstraZeneca, BMS and Noxopharm address findings of inquiry report into rare cancers

Health Industry Hub | May 20, 2024 |

Pharma News: The Senate Community Affairs References Committee has released its inquiry report into Equitable access to diagnosis and treatment […]

More


This content is copyright protected. Please subscribe to gain access.